Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial

JAMA

Volumn 276, Issue 17, 1996, Pages 1389-1396

  Mebane Sims, Irma ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; BONE DENSITY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN THERAPY; FEMALE; HIP; HUMAN; HUMAN EXPERIMENT; MULTICENTER STUDY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPINE;

EID: 0029907556     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.17.1389     Document Type: Article

References (48)

1. Stevenson JC, Bees B, Devenport M, et al. Determinants of bone density in normal women: risk factors for osteoporosis. BMJ. 1989;298:924-928.
2. Seeley DO, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR, for the Study of Osteoporotic Fractures Research Group. Which fractures are associated with low appendicular bone mass density in elderly women? Ann Intern Med. 1991;115:837-842.
3. Cummings SR, Black DM, Nevitt MC, et al, for the Study of Osteoporotic Fractures Research Group. Bone density at various sites for prediction of hip fractures. Lancet. 1993;341:72-75.
4. Black DM, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner W. Axial and appendicular bone density predict fractures in older women. J Bone Miner Res. 1992;7:633-638.
5. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med. 1994;330:1062-1071.
6. Cummings SR, Kelsey JL, Nevift MC, et al. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev. 1985;7:178-208.
7. Cooper C, Campion O, Melton LJ III. Hip fractures in the elderly: a world-wide projection. Osteopor Int. 1992;2:285-289.
8. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137-1141.
9. Looker AC, Johnston CC Jr, Wahner HW, et al. Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res. 1995;10:796-802.
10. Melton LJ III. How many women have osteoporosis now? J Bone Miner Res. 1995;10:175-177.
11. Grynpas M. Age and disease-related changes in the mineral of bone. Calcif Tissue Int. 1993;53:557-564.
12. Riggs BL, Wahner HW, Seeman E, et al. Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest. 1982; 70:716-723.
13. Riggs BL, Wahner HW, Melton LJ III, et al. Rates of bone loss in the appendicular and axial skeletons of women. J Clin Invest. 1986;77:1487-1491.
14. Lindsay R, MacLean A, Kraszewski A, et al. Bone response to termination of oestrogen treatment. Lancet. 1978;2:1325-1327.
15. Cauley JA, Seeley DO, Ensrud K, Ettinger B, Black D, Cummings SR, for the Study of Osteoporotic Fractures Research Group. Estrogen replacement therapy and fractures in older women. Ann Intern Med. 1995;122:9-16.
16. Session DR, Kelly AC, Jewelewicz R. Current concepts in estrogen replacement therapy in the menopause. Fertil Steril. 1993;59:277-284.
17. Lindsay R, Cosman F. Estrogen in prevention and treatment of osteoporosis. Ann N Y Acad Sci. 1990;592:326-333.
18. Holland EFN, Leather AT, Studd JWW. The effect of 25mg percutaneous estradiol implants on the bone mass of postmenopausal women. Obstet Gynecol. 1994;83:43-46.
19. Heaney EP. The bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res. 1994; 9:1515-1523.
20. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305-311.
21. Frost HM. Some effects of basic multicellular unit-based remodeling on photon absorptiometry of trabecular bone. Bone Miner. 1989;7:47-65.
22. Gallagher JC, Kable WT. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med. 1991;90:171-178.
23. Prior JC. Progesterone as a bone-trophic hormone. Endocr Rev. 1990;11:386-398.
24. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl Med. 1991;325:1189-1195.
25. Sowers MR, Clark MK, Jannausch ML, Wallace RB. Body size, estrogen use, and thiazide diuretic use affect 5-year radial bone loss in postmenopausal women. Osteopor Int. 1993;3:314-321.
26. Smith EL. Exercise for prevention of osteoporosis: a review. Physial Sports Med. 1982;10:72-83.
27. Greendale GA, Wells BW, Barrett-Connor E, et al. Lifestyle factors and bone mineral density: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial J Worn Health. 1995;4:231-446.
28. Grisso JA, Kelsy JL, Strom BL, et al, and the Northeast Hip Fracture Study Group. Risk factors for hip fracture in black women. N Engl J Med. 1994;330:1555-1559.
29. Jensen J, Christiansen C, Røtbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med. 1985;313:973-975.
30. Kiel DP, Baron JA, Andersen JJ, Hannan MT, Felson DT. Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Intern Med. 1992;116;716-721.
31. Jaglal SB, Kreiger N, Darlington G. Past and recent physical activity and risk of hip fracture. Am J Epidemiol. 1993;138:107-118.
32. Notelovitz M, Martin D, Tesar R, et al. Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women. J Bone Miner Res. 1991;6:583-590.
33. Armamento-Villareal R, Civitelli R. Estrogen action on the bone mass of postmenopausal women is dependent on body mass and initial bone density. J Clin Endocrinol Metab. 1995;80:776-782.
34. Sartoris DJ, Resnick D. Dual energy radiographic absorptiometry for bone densitometry: current status and perspective. Am J Radiol. 1989; 152:241-246.
35. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial Investigators. Rationale, design, and conduct of the PEPI Trial Contral Clin Trials. 1995;16:3S-19S.
36. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial Investigators. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopaueal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199-208. Correction: JAMA. 1996;274:1676.
37. Marcus R, Greendale G, Blunt BA, et al. Correlates of bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Trial. J Bone Miner Res. 1994;9:1467-1476.
38. SAS/STAT Software: Changes and Enhancements, Release 6.07. Gary, NC: SAS Institute Inc; 1992. SAS Technical Report P-229.
39. SAS Procedures Guide, Version 6.3rd ed. Cary, NC: SAS Institute Inc; 1990.
40. Odell WE, Heath H. Osteoporosis: pathophysiology, prevention, diagnosis, and treatment. Dis Mon. 1993;19:789-798.
41. Christiansen C, Riis BJ. Hormonal replacement therapy and the skeletal system. Maturitas. 1990; 12:247-257.
42. Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol. 1990;76:290-295.
43. Wimalawansa SJ. Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: fouryear randomized study. Am J Med. 1995;99:36-42.
44. Christiansen G, Riis BJ. 17β-Estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab. 1990;71:836-841.
45. Holland EFN, Leather AT, Studd JWW, Gamett TJ. The effect of a new sequential oestradiol valerate and levonorgestrel preparation on the bone mineral density of postmenopausal women. Br J Obstet Gynaecol 1993;100:966-967.
46. Riis BJ, Thomsen K, Strom BL, Christiansen C. The effect percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol. 1987;156:61-65.
47. Wood H, Wang-Cheng R, Nattinger AB. Postmenopausal hormone replacement: are two hormones better than one? J Gen Intern Med. 1993; 8:451-458.
48. Greendale GA, Hogan P, Kritz-Silvertein D, Langer R, Johnson SR, Bush T. Age at menopause in women participating in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial: an example of bias introduced by selection criteria. Menopause. 1995;2:27-34.